Title: Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.
Journal: Epilepsia 20160201
Title: Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.
Journal: Scientific reports 20160101
Title: Effect of gemfibrozil on the metabolism of brivaracetam in vitro and in human subjects.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120801
Title: Recent and future antiepileptic drugs and their impact on cognition: what can we expect?
Journal: Expert review of neurotherapeutics 20120601
Title: Clavulanic acid does not affect convulsions in acute seizure tests in mice.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20120101
Title: Rational polytherapy in the treatment of acute seizures and status epilepticus.
Journal: Epilepsia 20111001
Title: Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.
Journal: European journal of pharmacology 20110816
Title: Brivaracetam for the treatment of epilepsy.
Journal: Expert opinion on pharmacotherapy 20110801
Title: Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam.
Journal: Epilepsia 20110201
Title: Pharmacotherapy of epilepsy: newly approved and developmental agents.
Journal: CNS drugs 20110201
Title: Increased compactibility of acetames after roll compaction.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110101
Title: Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X).
Journal: Epilepsy research 20101201
Title: New drugs for pediatric epilepsy.
Journal: Seminars in pediatric neurology 20101201
Title: Emerging drugs for partial onset seizures.
Journal: Expert opinion on emerging drugs 20100901
Title: Brivaracetam does not alter spatial learning and memory in both normal and amygdala-kindled rats.
Journal: Epilepsy research 20100901
Title: Antiepileptic drug interactions - principles and clinical implications.
Journal: Current neuropharmacology 20100901
Title: Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial.
Journal: Neurology 20100810
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100401
Title: Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs.
Journal: Drugs of today (Barcelona, Spain : 1998) 20100401
Title: Physiologically based pharmacokinetic/pharmacodynamic animal-to-man prediction of therapeutic dose in a model of epilepsy.
Journal: Basic & clinical pharmacology & toxicology 20100301
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20100301
Title: Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.
Journal: Drugs 20100212
Title: Discovery of indolone acetamides as novel SV2A ligands with improved potency toward seizure suppression.
Journal: ChemMedChem 20100201
Title: Brivaracetam (ucb 34714) inhibits Na(+) current in rat cortical neurons in culture.
Journal: Epilepsy research 20100101
Title: What is the promise of new antiepileptic drugs in status epilepticus? Focus on brivaracetam, carisbamate, lacosamide, NS-1209, and topiramate.
Journal: Epilepsia 20091201
Title: Brivaracetam inhibits spreading depression in rat neocortical slices in vitro.
Journal: Seizure 20090701
Title: Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX).
Journal: Epilepsy research 20090101
Title: SVOP is a nucleotide binding protein.
Journal: PloS one 20090101
Title: Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions.
Journal: Pharmacological reports : PR 20090101
Title: Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster.
Journal: European journal of pharmacology 20081228
Title: Debate: Does genetic information in humans help us treat patients? PRO--genetic information in humans helps us treat patients. CON--genetic information does not help at all.
Journal: Epilepsia 20081201
Title: Treatment of Lennox-Gastaut syndrome: overview and recent findings.
Journal: Neuropsychiatric disease and treatment 20081201
Title: Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
Journal: British journal of pharmacology 20080801
Title: Brivaracetam: a rational drug discovery success story.
Journal: British journal of pharmacology 20080801
Title: Effect of brivaracetam on cardiac repolarisation--a thorough QT study.
Journal: Current medical research and opinion 20080801
Title: The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men.
Journal: British journal of clinical pharmacology 20080701
Title: New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels.
Journal: Current neurology and neuroscience reports 20080701
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080401
Title: Brivaracetam: a new drug in development for epilepsy and neuropathic pain.
Journal: Expert opinion on investigational drugs 20080301
Title: The effectiveness of anticonvulsants in psychiatric disorders.
Journal: Dialogues in clinical neuroscience 20080301
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080301
Title: Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080101
Title: Pharmacological management of epilepsy: recent advances and future prospects.
Journal: Drugs 20080101
Title: Modifications of antiepileptic drugs for improved tolerability and efficacy.
Journal: Perspectives in medicinal chemistry 20080101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20071201
Title: Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.
Journal: Neurology 20070904
Title: The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males.
Journal: British journal of clinical pharmacology 20070601
Title: [A new aspect in the research on antiepileptic drugs].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070201
Title: Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII).
Journal: Epilepsy research 20070101
Title: Brivaracetam (UCB 34714).
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20070101
Title: Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20070101
Title: Diverse mechanisms of antiepileptic drugs in the development pipeline.
Journal: Epilepsy research 20060601
Title: New antiepileptic drugs that are second generation to existing antiepileptic drugs.
Journal: Expert opinion on investigational drugs 20060601
Title: Brivaracetam UCB.
Journal: Current opinion in investigational drugs (London, England : 2000) 20050701
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20050101
Title: Antiepileptic drug discovery: lessons from the past and future challenges.
Journal: Acta neurologica Scandinavica. Supplementum 20050101
Title: Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.
Journal: Journal of medicinal chemistry 20040129
Title: Symposium: the city: a viable environment for the elderly? Phase III: planning and delivery of health services. Background.
Journal: The Gerontologist 19760201
